Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-03-21
2006-03-21
Gupta, Anisha (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S018700, C514S217000, C530S317000, C530S330000
Reexamination Certificate
active
07015196
ABSTRACT:
Basic monocyclic compounds having general formula (I) useful as NK-2 antagonists are described, processes for their preparation and pharmaceutical compositions containing them are also described.
REFERENCES:
patent: 033174 (1989-09-01), None
patent: WO9303059 (1993-02-01), None
patent: WO9321227 (1993-10-01), None
patent: WO9717362 (1997-05-01), None
patent: WO9834949 (1998-08-01), None
patent: WO0008046 (2000-02-01), None
Kudiacz et al., “Tachykinin-mediated Respiratory Effects in Conscious Guinea Pigs: Modulation by NK, and NK, Receptor Agonists”,European Journal of Pharmacology, 241, pgs. 17-25 (1993).
McKnight et al., “Pharmacological Specificity of Novel, Synthetic, Cyclic Peptides as Antagonists at Tachykinin Receptors”,J. Pharmacol. 104, 355-360 (1991).
Quartara et al., “Influence of Lipophilicity on the Biological Activity of Cyclic Pseudopeptide NK-2 Receptor Antagonist”,Journal of Medicinal Chemistry, (1994).
Peptides, Chemistry and Biology, Proceedings of the 12th American Peptide Symposium, Jun. 16-21, 1991, Cambridge Mass, Published by Escom (1992).
Altamura Maria
Giannotti Danilo
Giuliani Sandro
Maggi Carlo Alberto
Perrotta Enzo
Abelman ,Frayne & Schwab
Gupta Anisha
Menarini Ricerche S.p.A.
LandOfFree
Basic monocyclic compounds having Nk2 antagonist action,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Basic monocyclic compounds having Nk2 antagonist action,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Basic monocyclic compounds having Nk2 antagonist action,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3538635